News | July 31, 2025
Imfinzi granted Priority Review and Breakthrough Therapy Designation in US
For patients with resectable early-stage gastric and gastroesophageal junction cancers
For patients with resectable early-stage gastric and gastroesophageal junction cancers
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
NewCo’s pipeline includes five investigational medicines
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Subscribe To Our Newsletter & Stay Updated
